Insider trades

Stephen Mitchener, Chief Officer of Karyopharm Therapeutics KPTI, has filed 0 purchases and 1 sale on the open market. The latest trade was on 23/03/01.

Stephen Mitchener

SVP, Chief Business Officer
First filing
23/03/02
Trades
2 trades
Buys / sales
0 / 1
12-month net buying
No record
Last trade
23/03/01

Trading activity

Transactions

Trade type
Open-market sale23/03/0123/03/026,357 sh$3.03$19,261.71−4.7%